Elisabetta Sereni
Verona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment.
Journal: JCO precision oncology
Published: November 20, 2024
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study.
Journal: British journal of cancer
Published: October 26, 2024
What is the optimal surgical approach for ductal adenocarcinoma of the pancreatic neck? - a retrospective cohort study.
Journal: Langenbeck's archives of surgery
Published: March 29, 2024
The value of CA19-9 dynamics in decision making for treatment of locally advanced pancreatic cancer.
The value of CA19-9 dynamics in decision making for treatment of locally advanced pancreatic cancer.
Journal: Gland surgery
Published: November 21, 2023
Progression of Site-specific Recurrence of Pancreatic Cancer and Implications for Treatment.
Journal: Annals of surgery
Published: October 23, 2023
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 12, 2023
Characterization and digital spatial deconvolution of the immune microenvironment of intraductal oncocytic papillary neoplasms (IOPN) of the pancreas.
Journal: Virchows Archiv : an international journal of pathology
Published: January 18, 2023
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 07, 2022
Loss of FGFR4 promotes the malignant phenotype of PDAC.
Journal: Oncogene
Published: February 08, 2022
Last Updated: 09/26/2026